MicroHarvest develops a production platform for single-cell protein produced with bacteria, positioning it as an alternative protein ingredient supplier for human food. The company claims its proprietary technology produces protein at a speed and efficiency that exceeds existing approaches, enabling rapid scale-up and decentralised production. It targets the $14 billion alternative protein ingredients market and emphasizes nutritious, tasty and safe protein for B2B customers. With the new funding the startup plans to grow its R&D team, build a pilot plant in Lisbon and accelerate toward commercial-scale production. The raise is intended to bring the faster protein production system to commercialisation and increase MicroHarvest's relevance in ingredient supply chains. The company is based in Hamburg and highlights sustainability and localised production as key benefits of its platform.

Total raised

$10M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2023